Development and in-vivo evaluation of ondansetron gels for transdermal delivery

References

• Hesketh PJ. Chemotherapy-induced nausea and vomiting. New Engl J Med 2008;358:2482–94
   PubMed Web of Science ®Google Scholar
• Billio A, Morello E, Clarke MJ. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev 2010;(1): Art. No. CD006272. DOI: 10.1002/14651858.CD006272.pub2
   PubMed Web of Science ®Google Scholar
• del Giglio A, Soares HP, Caparroz C, Castro PC. Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials. Cancer 2000;89:2301–8
   PubMed Web of Science ®Google Scholar
• Al Abood RM, Talegaonkar S, Tariq M, Ahmad FJ. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting. Coll Surf B Biointer 2013;101:143–51
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR, Rama B, Raghumurthy V, et al. Effect of PEG6000 on the in-vitro and in-vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes. Pharm Dev Technol 2009;14:53–64
   Web of Science ®Google Scholar
• Gwak HS, Oh IS, Chun IK. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev Ind Pharm 2004;30:187–94
   PubMed Web of Science ®Google Scholar
• Pattnaik S, Swain K, Mallick S, Lin Z. Effect of casting solvent on crystallinity of ondansetron in transdermal films. Int J Pharm 2011;406:106–10
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR, Raju V, Shiva Kumar M, et al. Studies on optimizing in-vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers. Pharm Dev Technol 2008;13:177–85
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR, Kumar MS, Raju V, et al. Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis. Drug Deliv 2008;15:227–34
   PubMed Web of Science ®Google Scholar
• Edsman K, Hagerstrom H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57:3–22
   PubMed Web of Science ®Google Scholar
• Edsman K, Carlfors J, Harju K. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. Int J Pharm 1996;37:233–41
   Google Scholar
• Escobar-Chávez JJ, Bonilla-Martínez D, Villegas-González MA, et al. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol 2011;51:964–77
   PubMed Web of Science ®Google Scholar
• Zhang YT, Xu YM, Zhang SJ, et al. In vivo microdialysis for the evaluation of transfersomes as a novel transdermal delivery vehicle for cinnamic acid. Drug Dev Ind Pharm 2014;40:301--7
   Google Scholar
• Holmgaard R, Nielsen JB, Benfeldt ER. Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives. Skin Pharmacol Physiol 2010;23:225–43
   PubMed Web of Science ®Google Scholar
• Chaurasia CS, Müller M, Bashaw ED, et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res 2007;24:1014–25
   PubMed Web of Science ®Google Scholar
• Nakashima M, Zhao MF, Ohya H, et al. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats. J Pharm Pharmacol 1996;48:1143–6
   PubMed Web of Science ®Google Scholar
• Patel M, Joshi A, Hassanzadeth H, et al. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits. Drug Dev Ind Pharm 2011;37:613–17
   PubMed Web of Science ®Google Scholar
• Dimas D, Dallas P, Rekkas D. Use of an 8(1)3(2) asymmetrical factorial design for the in vitro evaluation of ondansetron permeation through human epidermis. Pharm Dev Technol 2004;9:39–48
   PubMed Web of Science ®Google Scholar
• Stagni G, O'Donnell D, Liu YJ, et al. Iontophoretic current and intradermal microdialysis recovery in humans. J Pharmacol Toxicol Meth 1999;41:49–54
   PubMed Web of Science ®Google Scholar
• Stagni G, Shukla C. Pharmacokinetics of methotrexate in rabbit skin and plasma after iv-bolus and iontophoretic administrations. J Control Release 2003;93:283–92
   PubMed Web of Science ®Google Scholar
• Higuchi WI. Analysis of data on the medicament release from ointments. J Pharmaceut Sci 1962;51:802–4
   PubMed Web of Science ®Google Scholar
• Patel DR, Stagni G. Evaluation of different penetration enhancers for transdermal delivery of an ondansetron gel. Poster presentation at the 2012 AAPS Annual Meeting and Exposition; October 14--17, 2012; Chicago, IL, Poster R6326
   Google Scholar
• Lizelle T Fox, Minja Gerber, Jeanetta Du Plessis, Josias H Hamman. Transdermal drug delivery enhancement by compounds of natural origin. Molecule 2011;16:10507–40
   Web of Science ®Google Scholar
• Engelbrecht TN, Demé B, Dobner B, Neubert RHH. Study of the influence of the penetration enhancer isopropyl myristate on the nanostructure of stratum corneum lipid model membranes using neutron diffraction and deuterium labelling. Skin Pharmacol Physiol 2012;25:200–7
   PubMed Web of Science ®Google Scholar
• Repetto MR, Repetto M. Concentrations in human fluids: 101 drugs affecting the digestive system and metabolism. Clin Toxicol 1999;37:1–8
   Web of Science ®Google Scholar
• Giordano J, Daleo C, Sacks SM. Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans. Eur J Pharmacol 1998;354:R13–14
   PubMed Web of Science ®Google Scholar
• Champion RH, Burns DA, Breathnach SM. Textbook of dermatology. London: Blackwell Science; 1998
   Google Scholar